| |
| |
|
| Insider
Information: |
Dibiase Mary |
| Relationship: |
Chief Operating Officer |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
291,752 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$318,010 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
291,752 |
|
|
| Total
Value |
$318,010 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
X4 Pharmaceuticals Inc |
XFOR |
Chief Operating Officer |
2024-03-11 |
291,752 |
2021-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2024-03-11 |
4 |
S |
$0.88 |
$13,591 |
D/D |
(15,409) |
291,752 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2024-02-12 |
4 |
S |
$1.01 |
$3,709 |
D/D |
(3,683) |
307,161 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2023-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
230,645 |
378,539 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2023-09-08 |
4 |
AS |
$1.25 |
$3,300 |
D/D |
(2,642) |
147,894 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2023-06-30 |
4 |
AS |
$1.89 |
$877 |
D/D |
(464) |
150,536 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2023-06-23 |
4 |
AS |
$1.93 |
$1,654 |
D/D |
(857) |
151,000 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2023-06-15 |
4 |
AS |
$2.23 |
$1,911 |
D/D |
(857) |
151,857 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2023-03-10 |
4 |
AS |
$0.84 |
$15,281 |
D/D |
(18,192) |
152,714 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2023-02-13 |
4 |
AS |
$0.93 |
$4,044 |
D/D |
(4,348) |
170,906 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2022-08-17 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,713) |
177,896 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2022-06-30 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,578) |
179,609 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2022-06-24 |
4 |
AS |
$0.00 |
$0 |
D/D |
(856) |
181,187 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2022-06-16 |
4 |
AS |
$0.00 |
$0 |
D/D |
(856) |
182,043 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
182,899 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2022-02-11 |
4 |
AS |
$0.00 |
$0 |
D/D |
(12,545) |
77,899 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating OfficerOfficer |
• – – |
2021-09-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,475 |
|
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2021-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
90,444 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
